Real-world effectiveness of pazopanib in patients with intermediate prognostic risk advanced renal cell carcinoma (PRINCIPAL study)

Analyses of Nivolumab Exposure and Clinical Safety Between 3-mg/kg Dosing and 240-mg Flat Dosing in Asian Patients with Advanced Renal Cell Carcinoma in the Real-World Clinical Setting

Translational Oncology ◽

10.1016/j.tranon.2020.100771 ◽

2020 ◽

Vol 13 (6) ◽

pp. 100771

Author(s):

Renpei Kato ◽

Daiki Ikarashi ◽

Tomohiko Matsuura ◽

Shigekatsu Maekawa ◽

Yoichiro Kato ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Real World ◽

Clinical Setting ◽

Renal Cell ◽

Clinical Safety ◽

The Real ◽

Asian Patients

Real-world Effectiveness and Safety of Pazopanib in Patients With Intermediate Prognostic Risk Advanced Renal Cell Carcinoma

Clinical Genitourinary Cancer ◽

10.1016/j.clgc.2019.01.018 ◽

2019 ◽

Vol 17 (3) ◽

pp. e526-e533 ◽

Cited By ~ 3

Author(s):

Giuseppe Procopio ◽

Aristotelis Bamias ◽

Manuela Schmidinger ◽

Robert Hawkins ◽

Angel Rodriguez Sánchez ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Real World ◽

Renal Cell ◽

Elderly patients (pts) with advanced Renal Cell Carcinoma (aRCC) treated with Nivolumab (N): A subgroup analysis from the WITNESS real-world study in France

European Urology Open Science ◽

10.1016/s2666-1683(20)36230-3 ◽

2020 ◽

Vol 21 ◽

pp. S182

Author(s):

P. Barthélémy ◽

A. Thiery-Vuillemin ◽

B. Escudier ◽

J-C. Eymard ◽

G. Mouillet ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Elderly Patients ◽

Cell Carcinoma ◽

Real World ◽

Subgroup Analysis ◽

Renal Cell ◽

Real world evidence in renal cell carcinoma: A national, prospective, non-interventional study of nivolumab in patients with advanced renal cell carcinoma after prior therapy (NORA)

European Urology Supplements ◽

10.1016/s1569-9056(19)31333-8 ◽

2019 ◽

Vol 18 (1) ◽

pp. e1841

Author(s):

M-O. Grimm ◽

V. Grünwald ◽

H. Müller-Huesmann ◽

M. Schostak ◽

W. Schultze-Seemann ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Real World ◽

Renal Cell ◽

Interventional Study ◽

Prior Therapy ◽

Real World Evidence

682P Real-world utilization and outcomes of immune-based combination therapies or tyrosine kinase inhibitors (TKIs) for advanced renal cell carcinoma (aRCC)

Annals of Oncology ◽

10.1016/j.annonc.2021.08.078 ◽

2021 ◽

Vol 32 ◽

pp. S702

Author(s):

D. Geynisman ◽

J.K. Kish ◽

A. Falkenstein ◽

V. Del Tejo ◽

B. Stwalley ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Tyrosine Kinase ◽

Cell Carcinoma ◽

Tyrosine Kinase Inhibitors ◽

Real World ◽

Renal Cell ◽

Kinase Inhibitors ◽

Combination Therapies

674P WITNESS: Real-world outcomes of patients (pts) with advanced renal cell carcinoma (aRCC) treated with nivolumab in France and subgroup analysis of patients receiving concomitant medications at baseline

Annals of Oncology ◽

10.1016/j.annonc.2021.08.070 ◽

2021 ◽

Vol 32 ◽

pp. S697

Author(s):

A. Thiery-Vuillemin ◽

L. Albiges ◽

B. Escudier ◽

B. Narciso ◽

P. Bigot ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Real World ◽

Subgroup Analysis ◽

Renal Cell ◽

Concomitant Medications

Real-World Data on the Use of Nivolumab Monotherapy in the Treatment of Advanced Renal Cell Carcinoma after Prior Therapy: Interim Results from the Noninterventional NORA Study

European Urology Focus ◽

10.1016/j.euf.2021.11.006 ◽

2021 ◽

Author(s):

Marc-Oliver Grimm ◽

Viktor Grünwald ◽

Harald Müller-Huesmann ◽

Philipp Ivanyi ◽

Martin Schostak ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Real World ◽

Renal Cell ◽

Real World Data ◽

World Data ◽

Prior Therapy

Real-world use of sunitinib in Japanese patients with advanced renal cell carcinoma: efficacy, safety and biomarker analyses in 1689 consecutive patients

Japanese Journal of Clinical Oncology ◽

10.1093/jjco/hyv045 ◽

2015 ◽

Vol 45 (6) ◽

pp. 576-583 ◽

Cited By ~ 27

Author(s):

Hideyuki Akaza ◽

Seiji Naito ◽

Naomi Ueno ◽

Kouji Aoki ◽

Hiroyuki Houzawa ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Real World ◽

Renal Cell ◽

Japanese Patients ◽

Real world experience and biomarkers of nivolumab in dutch advanced renal-cell carcinoma patients.

Journal of Clinical Oncology ◽

10.1200/jco.2018.36.15_suppl.4572 ◽

2018 ◽

Vol 36 (15_suppl) ◽

pp. 4572-4572

Author(s):

Saskia Lisa Verhaart ◽

Carla M.L.- Van Herpen ◽

Sjoukje Oosting ◽

Astrid Van Der Veldt ◽

Susanne Osanto ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Real World ◽

Renal Cell ◽

Real-world Clinical Outcomes of Pazopanib Immediately After Discontinuation of Immunotherapy for Advanced Renal Cell Carcinoma

Clinical Genitourinary Cancer ◽

10.1016/j.clgc.2019.10.010 ◽

2020 ◽

Vol 18 (1) ◽

pp. e37-e45 ◽

Cited By ~ 3

Author(s):

Xiting Cao ◽

Derek Tang ◽

Barbara Ratto ◽

Austin Poole ◽

Shoba Ravichandran ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Clinical Outcomes ◽

Real World ◽

Renal Cell ◽